Cargando…
Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)
Acute myeloid leukemia (AML) with inv(3)(q21q26.2)/t(3;3)(q21;q26.2) has a very poor prognosis. Determinants of clinical outcomes and optimal treatment remain uncertain. We retrospectively reviewed 108 cases of AML with inv(3)/t(3;3) and evaluated clinicopathological characteristics and clinical out...
Autores principales: | Richard-Carpentier, Guillaume, Rausch, Caitlin R., Sasaki, Koji, Hammond, Danielle, Morita, Kiyomi, Takahashi, Koichi, Tang, Guilin, Kanagal-Shamanna, Rashmi, Bhalla, Kapil, Dinardo, Courtney D., Borthakur, Gautam, Pemmaraju, Naveen, Shpall, Elizabeth J., Alousi, Amin, Daver, Naval G., Garcia-Manero, Guillermo, Konopleva, Marina Y., Ravandi, Farhad, Kantarjian, Hagop M., Kadia, Tapan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483357/ https://www.ncbi.nlm.nih.gov/pubmed/36951163 http://dx.doi.org/10.3324/haematol.2022.282030 |
Ejemplares similares
-
Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: a case report
por: Lewen, Margaret, et al.
Publicado: (2016) -
Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression
por: Gu, Jun, et al.
Publicado: (2015) -
An Interstitial Deletion at 10q26.2q26.3
por: Iourov, Ivan Y., et al.
Publicado: (2014) -
3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features
por: Tang, Zhenya, et al.
Publicado: (2023) -
Targeting ncRNAs in the 3q26.2 amplicon
por: Chaluvally-Raghavan, Pradeep, et al.
Publicado: (2015)